Breaking News, Promotions & Moves

Cambrex Names Tom Vadaketh EVP and CFO

Greg Sargen to take up new post as EVP, corporate development and strategy

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex Corporation has named Tom Vadaketh executive vice president and chief financial officer, effective January 20, 2017. Greg Sargen, current chief financial officer at Cambrex, will transition to a newly created role, executive vice president, corporate development and strategy. In his new role, Mr. Sargen will assume responsibility for corporate development and strategy and will continue to report directly to Steven Klosk, president and chief executive officer.

“We are excited to welcome Tom. He has an impressive track record and brings a wide variety of experiences across all financial disciplines to Cambrex,” said Mr. Klosk. “I am confident that Tom’s experience in senior corporate roles, especially with manufacturing organizations and facilities, will be invaluable to Cambrex. Tom and Greg will work closely together to ensure a seamless transition.
 
“Greg has led the finance team and has been a trusted business partner during his many years at Cambrex. In his new role, Greg will apply his business acumen, industry knowledge and intimate knowledge of the company to identify and execute on new growth opportunities, including investment in potential new product categories and capabilities, as well as mergers and acquisitions.”

Mr. Vadaketh was most recently the chief financial officer of the Crosby Group, a private equity-owned company and a world leader in the manufacture of rigging, lifting and material handling applications. Prior to that, he spent nine years in a variety of increasingly senior financial positions at Tyco International.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters